Takeda

a lot of scissors
Biotech

Takeda shoots down bispecifics bagged in Maverick buyout

The two bispecific terminations, coupled to the removal of a third asset, halved the number of cancer candidates in Takeda’s phase 1 and 2 pipeline.
Nick Paul Taylor May 8, 2025 8:30am
fence palisade wall defense fence gate fortress fort

Keros mulls sale, strengthens defense against activist investors

Apr 10, 2025 8:44am
neon closed sign in window

Arch-backed tRNA biotech shutters after viewing preclinical data

Mar 18, 2025 10:15am
Abstract 3D Geometric Shapes Cube Blocks Background

Takeda's oncology execs sharpen focus after restructuring

Mar 13, 2025 10:59am
Graphic of a drop of blood made up of small data points and nodes

Takeda's $300M bet on Protagonist's blood cancer drug pays off

Mar 3, 2025 8:45am
Three blocks displaying from left to right a person a handshake and another person

Takeda fronts $46M for 2nd small molecule collab with BridGene

Feb 25, 2025 8:00am